Procalcitonin not only in the differential diagnosis of the inflammatory response;Prokalcitonin nejen v diferenciální diagnostice zánětlivé odpovědi organismu

Anesteziologie a Neodkladna Pece

Volumn 13, Issue 2, 2002, Pages 86-91

  Zazula, Roman ^a   Prucha M ^a   Spaleny A ^a   Jaresova M ^a   Vitko S ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Infection; Liver transplant patients; Pan T cell antibodies; Procalcitonin; Sepsis

Indexed keywords

C REACTIVE PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; POLYCLONAL ANTIBODY; PROCALCITONIN;

ANESTHESIA INDUCTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LEUKOCYTE COUNT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RELIABILITY; SEPSIS; SEPTIC SHOCK; SERUM;

EID: 0036125744     PISSN: 08624968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Calcitonin gene expression in normal human liver
2. Katacalcin a calcitonin immunoreactivity in different types of leukocytes indicates intracellular procalcitonin content
3. Pneumonitis associated hyperprocalcitonemia
4. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock
5. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
6. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis
7. Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation
8. Procalcitonin - A new diagnostic tool in complications following liver transplantation
9. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro
10. Procalcitonin - The specific marker of infectious inflammation
11. Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies